Evidence map›Paper›PMID 37202925›Full record

ArticleAnimal models and experimental medicine2024

Perilipin 5 regulates hepatic stellate cell activation and high-fat diet-induced non-alcoholic fatty liver disease.

Xuecui Yin, Lin Dong, Xiaohan Wang, Zhenzhen Qin, Yuying Ma, Xiaofei Ke, Ya Li, Qingde Wang, Yang Mi, Quanjun Lyu and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Animal models and experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Molecular medicine reports · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Biology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Xuecui YinDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID 0000-0003-0355-9435
Lin DongDepartment of Pediatrics, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID 0000-0001-8769-5447
Xiaohan WangDepartment of Pediatrics, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhenzhen QinDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yuying MaDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaofei KeDepartment of Pediatrics, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Ya LiDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qingde WangDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yang MiDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Quanjun LyuDepartment of Clinical Nutrition, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xia XuKey Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Co-innovation Center of Henan Province for New drug R & D and Preclinical Safety, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Pengyuan ZhengDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Youcai TangDepartment of Internal Medicine, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Fifth Affiliated Hospital of Zhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CNMinistry of Education · NZ

Funding

Discipline Key Special Project XKZDQY202001Henan Provincial Key R&D and Promotion Special Project 212102310033Henan Provincial Medical Science and Technology Tackling Program LHGJ20220557Key R&D Program of China 2020YFC2006100Key R&D Program of China 2020YFC2009000Key R&D Program of China 2020YFC2009006National Natural Science Foundation of China 31471330National Natural Science Foundation of China 81870408
6 · The paper itself

Abstract

backgroundNonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases globally. Hepatic stellate cells (HSCs) are the major effector cells of liver fibrosis. HSCs contain abundant lipid droplets (LDs) in their cytoplasm during quiescence. Perilipin 5 (PLIN 5) is a LD surface-associated protein that plays a crucial role in lipid homeostasis. However, little is known about the role of PLIN 5 in HSC activation.

methodsPLIN 5 was overexpressed in HSCs of Sprague-Dawley rats by lentivirus transfection. At the same time, PLIN 5 gene knockout mice were constructed and fed with a high-fat diet (HFD) for 20 weeks to study the role of PLIN 5 in NAFLD. The corresponding reagent kits were used to measure TG, GSH, Caspase 3 activity, ATP level, and mitochondrial DNA copy number. Metabolomic analysis of mice liver tissue metabolism was performed based on UPLC-MS/MS. AMPK, mitochondrial function, cell proliferation, and apoptosis-related genes and proteins were detected by western blotting and qPCR.

resultsOverexpression of PLIN 5 in activated HSCs led to a decrease in ATP levels in mitochondria, inhibition of cell proliferation, and a significant increase in cell apoptosis through AMPK activation. In addition, compared with the HFD-fed C57BL/6J mice, PLIN 5 knockout mice fed with HFD showed reduced liver fat deposition, decreased LD abundance and size, and reduced liver fibrosis.

conclusionThese findings highlight the unique regulatory role of PLIN 5 in HSCs and the role of PLIN 5 in the fibrosis process of NAFLD.

Indexed as

Diet, High-FatHepatic Stellate CellsMice, KnockoutNon-alcoholic Fatty Liver DiseasePerilipin-5Rats, Sprague-DawleyAnimalsApoptosisCell ProliferationMaleMiceMice, Inbred C57BLRatsPerilipin-5Plin5 protein, mousePLIN5 protein, ratAMPKapoptosishepatic stellate cellliver fibrosisperilipin 5

Identifiers

PMID37202925
PMCPMC11079159
OpenAlexW4377093354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.